Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 02-Jun-23 5:49 PM View:  | Adicet Bio, Inc. (ACET) | 01-Jun-23 | Grant | 5,900 | -- | -- | 100% 0 to 5.9K | |
| 09-May-23 4:15 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 08-May-23 | Sale (Planned) | 2,850 | $350.00 | $997,500.00 | (8%) 34.89K to 32.04K | |
| 09-May-23 4:15 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 05-May-23 | Private Sale (Planned) | 422 | $350.03 | $147,713.00 | (1%) 35.31K to 34.89K | |
| 04-May-23 10:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-May-23 | Sale (Planned) | 2,781 | $350.74 | $975,418.00 | (7%) 38.09K to 35.31K | |
| 04-May-23 10:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-May-23 | Private Sale (Planned) | 1,622 | $350.66 | $568,768.00 | (4%) 39.71K to 38.09K | |
| 14-Apr-23 4:19 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 12-Apr-23 | Private Sale (Planned) | 7,567 | $326.70 | $2,472,160.00 | (16%) 47.28K to 39.71K | |
| 06-Apr-23 4:23 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 04-Apr-23 | Private Sale (Planned) | 522 | $315.81 | $164,854.00 | (1%) 47.8K to 47.28K | |
| 04-Apr-23 4:20 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 31-Mar-23 | Payment of Exercise | 1,466 | $313.74 | $459,943.00 | (3%) 49.27K to 47.8K | |
| 20-Mar-23 4:26 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 16-Mar-23 | Private Sale (Planned) | 2,746 | $300.59 | $825,423.00 | (5%) 52.01K to 49.27K | |
| 28-Feb-23 5:09 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-23 | Payment of Exercise | 3,970 | $289.12 | $1,147,810.00 | (7%) 55.98K to 52.01K | |
| 22-Feb-23 10:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Feb-23 | Payment of Exercise | 3,750 | $292.85 | $1,098,190.00 | (6%) 59.73K to 55.98K | |
| 16-Feb-23 4:16 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 14-Feb-23 | Private Sale (Planned) | 2,181 | $300.39 | $655,161.00 | (4%) 61.91K to 59.73K | |
| 14-Feb-23 5:08 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-Feb-23 | Payment of Exercise | 4,340 | $298.26 | $1,294,450.00 | (7%) 66.37K to 62.03K | |
| 14-Feb-23 5:08 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-Feb-23 | Sale (Planned) | 113 | $300.39 | $33,944.10 | (< 1%) 62.03K to 61.91K | |
| 14-Feb-23 5:08 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Feb-23 | Payment of Exercise | 902 | $294.33 | $265,486.00 | (1%) 67.27K to 66.37K | |
| 03-Feb-23 4:58 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Feb-23 | Grant | 29,272 | -- | -- | 77% 38.0K to 67.27K | |
| 02-Feb-23 4:18 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 31-Jan-23 | Private Sale (Planned) | 106 | $325.00 | $34,450.00 | (< 1%) 38.1K to 38.0K | |
| 03-Nov-22 4:05 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-Nov-22 | Sale (Planned) | 320 | $312.64 | $100,045.00 | (< 1%) 38.42K to 38.1K | |
| 03-Nov-22 4:05 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Nov-22 | Payment of Exercise | 768 | $312.84 | $240,261.00 | (2%) 39.19K to 38.42K | |
| 20-Oct-22 4:11 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 18-Oct-22 | Private Sale (Planned) | 1,791 | $300.31 | $537,860.00 | (4%) 40.98K to 39.19K | |
| 03-Aug-22 4:05 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Aug-22 | Payment of Exercise | 766 | $276.62 | $211,891.00 | (2%) 41.75K to 40.98K | |
| 18-May-22 4:22 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 16-May-22 | Private Sale (Planned) | 45 | $252.83 | $11,377.30 | (< 1%) 41.79K to 41.75K | |
| 06-May-22 4:05 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 04-May-22 | Private Sale (Planned) | 36 | $275.09 | $9,903.24 | (< 1%) 41.7K to 41.66K | |
| 04-May-22 5:10 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-May-22 | Private Sale (Planned) | 320 | $259.15 | $82,929.70 | (< 1%) 42.02K to 41.7K | |
| 03-May-22 4:26 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 29-Apr-22 | Payment of Exercise | 766 | $276.17 | $211,546.00 | (2%) 42.78K to 42.02K | |
| 08-Apr-22 4:34 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-Apr-22 | Private Sale (Planned) | 561 | $276.18 | $154,935.00 | (1%) 43.34K to 42.78K | |
| 06-Apr-22 5:02 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 05-Apr-22 | Sale (Planned) | 3,163 | $275.23 | $870,552.00 | (7%) 46.51K to 43.34K | |
| 06-Apr-22 5:02 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 04-Apr-22 | Private Sale (Planned) | 562 | $267.71 | $150,452.00 | (1%) 47.07K to 46.51K | |
| 05-Apr-22 4:05 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Apr-22 | Payment of Exercise | 1,344 | $263.09 | $353,593.00 | (3%) 48.41K to 47.07K | |
| 21-Mar-22 4:10 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Mar-22 | Private Sale (Planned) | 2,122 | $250.06 | $530,627.00 | (4%) 50.53K to 48.41K | |
| 22-Feb-22 5:02 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Feb-22 | Payment of Exercise | 3,439 | $232.51 | $799,602.00 | (6%) 53.97K to 50.53K | |
| 14-Feb-22 10:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Feb-22 | Payment of Exercise | 979 | $237.74 | $232,747.00 | (2%) 54.95K to 53.97K | |
| 03-Feb-22 4:26 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-Feb-22 | Sale (Planned) | 1,040 | $250.98 | $261,017.00 | (2%) 55.99K to 54.95K | |
| 03-Feb-22 4:26 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Feb-22 | Grant | 23,942 | -- | -- | 73% 32.58K to 56.52K | |
| 03-Feb-22 4:26 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Feb-22 | Payment of Exercise | 526 | $243.64 | $128,155.00 | (< 1%) 56.52K to 55.99K | |
| 03-Nov-21 4:09 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Nov-21 | Payment of Exercise | 766 | $185.07 | $141,764.00 | (2%) 33.34K to 32.58K | |
| 19-May-21 4:10 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-May-21 | Private Sale (Planned) | 112 | $216.34 | $24,230.10 | (< 1%) 34.22K to 34.11K | |
| 05-May-21 9:23 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-May-21 | Sale (Planned) | 960 | $218.43 | $209,691.00 | (3%) 35.07K to 34.11K | |
| 05-May-21 9:23 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 30-Apr-21 | Payment of Exercise | 766 | $217.21 | $166,383.00 | (2%) 35.83K to 35.07K | |
| 07-Apr-21 4:04 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 05-Apr-21 | Private Sale (Planned) | 1,686 | $214.14 | $361,046.00 | (4%) 37.52K to 35.83K | |
| 05-Apr-21 4:02 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Apr-21 | Payment of Exercise | 1,344 | $214.16 | $287,831.00 | (3%) 38.86K to 37.52K | |
| 16-Feb-21 4:22 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 11-Feb-21 | Private Sale (Planned) | 1,686 | $210.57 | $355,012.00 | (4%) 40.55K to 38.86K | |
| 12-Feb-21 4:14 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Feb-21 | Payment of Exercise | 1,344 | $214.16 | $287,831.00 | (3%) 41.89K to 40.55K | |
| 05-Feb-21 4:56 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Feb-21 | Grant | 20,719 | -- | -- | 98% 21.18K to 41.89K |